Loading...
Strategic Advisory Panel 2017-11-08T06:24:12+00:00

Composed of experienced leaders from across the health care system, the Strategic Advisory Panel helps set IVI research priorities, steers the research agenda in collaboration with scientific leadership, and provides guidance on ongoing research efforts. Panel members represent diverse perspectives from across the health care community, including academia, patient advocates, payers, providers, and the life sciences industry. Their role is to provide advice and ensure the credibility and rigor in the research and policy products, and to ensure all parties have a voice in IVI activities.

Formation Documents

Learn more about the Strategic Advisory Panel and its role.

Learn More

Chair and Vice-Chair

Samuel Nussbaum, MD

Chair, Strategic Advisory Panel
FULL BIO

Darius Lakdwalla, PhD

Vice-Chair, Strategic Advisory Panel
FULL BIO

Advisors

Alan Balch, PhD

Patient Advocate Foundation
FULL BIO

John Bulger, DO, MBA

Geisinger Health Plan
FULL BIO

Randy Burkholder

PhRMA
FULL BIO

Wayne Burton, MD

American Express (Former)
FULL BIO

Robert Dubois, MD, PhD

National Pharmaceutical Council
FULL BIO

Daniel Durham, MPP

Biotechnology Innovation Organization
FULL BIO

Patricia Fritz

UBC, Inc.
FULL BIO

Jan Hansen, PhD

Genentech
FULL BIO

Sachin Kamal-Bahl, PhD

Pfizer, Inc.
FULL BIO

Gregg Meyer, MD, MSc

Partners Healthcare System
FULL BIO

Michael Millenson

Health Quality Advisors LLC
FULL BIO

Joshua Ofman, MD, MSHS

Amgen, Inc.
FULL BIO

Michael Ryan, PharmD

Bristol-Myers Squibb
FULL BIO

Dana Gelb Safran, ScD

Blue Cross Blue Shield of Massachusetts
FULL BIO

Michael Sherman, MD

Harvard Pilgrim Health Care
FULL BIO

Susan Shiff, PhD, MBA

Merck
FULL BIO

William Shrank, MD, MSHS

UPMC Health Plan
FULL BIO

Vipan Sood, MBA

AbbVie
FULL BIO

Neil Weissman, MD

MedStar Health Research Institute
FULL BIO